GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma
The emergence of sorafenib resistance has become a predominant impediment and formidable dilemma in the therapeutic approach for hepatocellular carcinoma (HCC). Although the approval of next-generation drugs as alternatives to sorafenib is a significant development, the concurrent use of inhibitors...
Saved in:
| Main Authors: | Shiwen Ma, Fei Xie, Xiaohu Wen, Yao Mawulikplimi Adzavon, Ruping Zhao, Jinyi Zhao, Han Li, Yanqi Li, Jingtao Liu, Chen Liu, Yang Yi, Pengxiang Zhao, Boqing Wang, Wei Zhao, Xuemei Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661824004353 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational insights into the inhibitory effects of PFAS 14 on colorectal cancer targeting GSTA1 through competitive binding
by: Jinxiao Li, et al.
Published: (2025-03-01) -
Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model
by: Kuan He, et al.
Published: (2025-08-01) -
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
by: Xue Li, et al.
Published: (2024-12-01) -
The Radiosensitizing Effect of Tumor-Derived Microparticles Co-Loaded with Sorafenib and Gold Nanoparticles on Hepatocellular Carcinoma
by: Yu L, et al.
Published: (2025-04-01) -
Integrative single-cell RNA sequencing and bulk RNA sequencing reveals the characteristics of glutathione metabolism and protective role of GSTA4 gene in pancreatic cancer
by: Xinya Jia, et al.
Published: (2025-05-01)